Half a diagnosis: Gap in confirming infection among hepatitis c antibody-positive patients

American Journal of Medicine

Volumn 126, Issue 8, 2013, Pages 718-722

  McGibbon, Emily ^a   Bornschlegel, Katherine ^a   Balter, Sharon ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

Hepatitis C; Surveillance; Testing

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; FOLLOW UP; HEALTH SURVEY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PRISON;

HEPATITIS C; SURVEILLANCE; TESTING;

FEMALE; GUIDELINE ADHERENCE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; NEW YORK CITY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RNA, VIRAL;

EID: 84880600109     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.01.031     Document Type: Article

References (26)

1. Institute of Medicine (IOM) Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C 2010 The National Academies Press Washington, DC
2. United States Department of Health & Human Services Combating The Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis 2010 United States Department of Health & Human Services Washington, DC
3. G.L. Armstrong, A. Wasley, and E.P. Simard The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 10 2006 705 714
4. K. Bornschlegel, M. Berger, and R.K. Garg Prevalence of hepatitis C infection in New York City, 2004 J Urban Health 86 6 2009 909 917
5. M.G. Ghany, D.B. Strader, and D.L. Thomas Diagnosis, management, and treatment of hepatitis C: an update Hepatology 49 4 2009 1335 1374
6. B.D. Smith, R.L. Morgan, and G.A. Beckett Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965 MMWR Recomm Rep 61 RR-4 2012 1 32
7. D.B. Rein, B.D. Smith, and J.S. Wittenborn The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings Ann Intern Med 156 4 2012 263 270
8. J.H. Hoofnagle Course and outcome of hepatitis C Hepatology 36 5 Suppl 1 2002 S21 S29
9. I.M. Jacobson, J.G. McHutchison, and G. Dusheiko Telaprevir for previously untreated chronic hepatitis C virus infection N Engl J Med 364 25 2011 2405 2416
10. F. Poordad, J. McCone Jr., and B.R. Bacon Boceprevir for untreated chronic HCV genotype 1 infection N Engl J Med 364 13 2011 1195 1206
11. New York State Department of Health Medicaid Payment to Laboratories for Hepatitis C Tests Office of Medicaid Management DOH Medicaid Update 18 7 2003 Available at: http://www.health.ny.gov/health-care/medicaid/program/update/2003/ jul2003.htm#hepc Accessed November 20, 2012.
12. C.A. Rongey, F. Kanwal, and T. Hoang Viral RNA testing in hepatitis C antibody-positive veterans Am J Prev Med 36 3 2009 235 238
13. A.C. Moorman, S.C. Gordon, L.B. Rupp Chronic Hepatitis Cohort Study Investigators Baseline characteristics and mortality among people in care for chronic viral hepatitis: the Chronic Hepatitis Cohort Study Clin Infect Dis 56 1 2013 40 50
14. J.M. Ferrante, D.G. Winston, P.H. Chen, and A.N. de la Torre Family physicians' knowledge and screening of chronic hepatitis and liver cancer Fam Med 40 5 2008 345 351
15. M.J. Alter, W.L. Kuhnert, L. Finelli Centers for Disease Control and Prevention Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention MMWR Recomm Rep 52 RR-3 2003 1 13 15; quiz CE11-14
16. New York City Department of Health and Mental Hygiene. Hepatitis A, B and C Surveillance Report 2008-2009. Available at: http://www.nyc.gov/html/doh/ html/data/cd-hepabc-reports.shtml. Accessed November 20, 2012.
17. New York City Department of Health and Mental Hygiene. City health information: diagnosing and managing hepatitis C. Available at: http://www.nyc.gov/html/doh/downloads/pdf/chi/chi29-7.pdf. Accessed November 20, 2012.
18. R.D. Burt, H. Thiede, and H. Hagan Serosorting for hepatitis C status in the sharing of injection equipment among Seattle area injection drug users Drug Alcohol Depend 105 3 2009 215 220
19. P. Farci, H.J. Alter, and S. Govindarajan Lack of protective immunity against reinfection with hepatitis C virus Science 258 5079 1992 135 140
20. K. Bornschlegel, K.J. Crotty, S. Sahl, and S. Balter Unmet needs among people reported with hepatitis C, New York City J Public Health Manag Pract 17 4 2011 E9 E17
21. E. McGibbon, E. Amoroso, and A. Baptiste-Norville Surveillance for chronic hepatitis B virus infection - New York City, June 2008-November 2009 MMWR Morb Mortal Wkly Rep 61 1 2012 6 9
22. M.C. Samuel, A.R. Mocello, and D. Gilson California gonorrhea surveillance system: methodologic aspects and key results of a sample-based system Public Health Rep 124 Suppl 2 2009 87 97
23. Lyme disease per 100,000 population. New York State Community Health Data Set, 2011. Available at: http://www.health.ny.gov/statistics/chac/general/lyme. htm. Accessed January 4, 2013.
24. A.X. Garg, N.K. Adhikari, and H. McDonald Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review JAMA 293 10 2005 1223 1238
25. Centers for Disease Control and Prevention Interpretation and use of the western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections MMWR Morb Mortal Wkly Rep 38 Suppl 7 1989 1 7
26. Check Hep C. Check Hep C program flyer. Available at: http://nychepbc.org/wp-content/uploads/2012/06/Check-Hep-C-Program-Flyer.pdf. Accessed November 20, 2012.